2-(4-Aminopyridin-2-yl)propan-2-ol, 98%, 1g

Pointes de pipettes UNIVERSELLES 1–300 μl, Boîte, 960 pièces, Non stériles, 960 pièces

1-(Piperazin-1-yl)-3-(thiophen-2-ylthio)propan-2-ol, 97.0%, 250mg

4-methyl-1H-imidazole-2-carboxylic acid hydrate, 95.0%, 250mg

6-CHLORO-8-METHYL-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE, 95.0%, 1g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with (3S,4S)-1,1-dimethylethyl 3-hydroxy-4-(methylamino)-1-pyrrolidinecarboxylate (1:1), 98%, 100mg

(S)-3-Acetyl-4-isopropylthiazolidine-2-thione, 97%, 1g

5-ethyl-1H-1,2,4-triazole-3-thiol, 100mg

4-Chloro-n-[2-(morpholin-4-yl)ethyl]-3-nitrobenzene-1-sulfonamide, 98%, 100mg

N-(2-chloro-4-methylpyridin-3-yl)-2-(cyclopropylamino)nicotinamide, 98%, 250mg

Chariot pliant, cadre en aluminium, L 995 x l 620 x H 965 mm 1 Pièce

4-Oxazolecarboxamide, 2-(2-chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-, 250mg

2-(2-Ethoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one, 95.0%, 250mg